🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A new blog post by our CEO, Professor Paul Workman, looks at a study published today that identifies a new targeted drug treatment for a rare and difficult-to-treat cancer called #chordoma, the disease from which his mother died. buff.ly/2CxwfA2

Very excited that our paper on chordoma dependencies is now online Nature Medicine: nature.com/articles/s4159… rdcu.be/bhO4x Thank you to an incredible team of mentors and collaborators! Stuart Schreiber Joanne Kotz @chasz43 Chordoma Foundation #chordoma

Many thanks to Tom Ulrich and the Broad Communications team for so clearly describing our recent study on #chordoma Nature Medicine: broadinstitute.org/node/446056/

Yesterday nature highlighted that half of pediatric #cancer goes undiagnosed nature.com/articles/d4158… Today Science Magazine has multiple papers on pediatric cancer, #genomics, data sharing and more science.sciencemag.org/content/363/64… science.sciencemag.org/content/363/64…

Excited to share our preprint on mapping genetic dependencies and nominating new therapeutic targets in #chordoma. Huge thanks to the team, especially Stuart Schreiber, Mathias Wawer, Chordoma Foundation, and the patients who help support and motivate the work. doi.org/10.1101/2022.0…

Now online Nature Communications: our study describing an expanded map of genetic dependencies in #chordoma, revealing new potential therapeutic targets (e.g., SHP2). Very special thanks to Stuart Schreiber, Mathias Wawer, and Chordoma Foundation! nature.com/articles/s4146…